Division 5.2.3 Safety studiesF1F2

Safety studies shall address the following aspects:

1. (a)

   emergence of replication competent vector;

2. (b)

   emergence of new strains;

3. (c)

   reassortment of existing genomic sequences;

4. (d)

   neoplastic proliferation due to insertional mutagenicity.